We are live on ! Find out more
BG

Bellevue Group Portfolio holdings

AUM $4.2B
1-Year Est. Return 54.85%
This Fund
S&P 500
This Quarter Est. Return
+0.5%
1 Year Est. Return
+54.85%
3 Year Est. Return
+140.3%
5 Year Est. Return
+171.01%
10 Year Est. Return
+915.55%
AUM
$9.7B
AUM Growth
-$152M
Cap. Flow
+$293M
Cap. Flow %
3.03%
Top 10 Hldgs %
29.73%
Holding
234
New
14
Increased
60
Reduced
64
Closed
43

Top Buys

Rank Stock Value
1
CDNA icon
CareDx
CDNA
+$74.9M
2
ABT icon
Abbott
ABT
+$45.9M
3
MOH icon
Molina Healthcare
MOH
+$43.5M
4
DHR icon
Danaher
DHR
+$42M
5
MDT icon
Medtronic
MDT
+$38M

Top Sells

Rank Stock Value
1
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$63.1M
2
BAX icon
Baxter International
BAX
+$38.1M
3
CNC icon
Centene
CNC
+$36.2M
4
HOLX
Hologic
HOLX
+$21.4M
5
DXCM icon
DexCom
DXCM
+$16.5M

Sector Composition

Rank Sector Weight
1 Healthcare 97.85%
2 Technology 0.8%
3 Industrials 0.75%
4 Communication Services 0.02%
5 Energy 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BDX icon
26
Becton Dickinson
BDX
$42.9B
$115M 1.18%
466,797
-164
-0% -$39.3K
JAZZ icon
27
Jazz Pharmaceuticals
JAZZ
$15.4B
$113M 1.16%
886,854
+117,616
+15% +$15.5M
SYK icon
28
Stryker
SYK
$123B
$113M 1.16%
421,884
-448
-0.1% -$118K
AXNX
29
DELISTED
Axonics, Inc. Common Stock
AXNX
$105M 1.08%
1,872,014
+263,220
+16% +$16.1M
PODD icon
30
Insulet
PODD
$11.6B
$102M 1.05%
382,723
-271
-0.1% -$78.6K
MOH icon
31
Molina Healthcare
MOH
$12B
$100M 1.03%
314,582
+146,327
+87% +$43.5M
INSP icon
32
Inspire Medical Systems
INSP
$1.51B
$96.8M 1%
420,780
-278
-0.1% -$67.9K
ALGN icon
33
Align Technology
ALGN
$12.5B
$96.3M 0.99%
146,564
-10,467
-7% -$6.73M
MYOV
34
DELISTED
Myovant Sciences Ltd.
MYOV
$96.1M 0.99%
6,169,039
+400,000
+7% +$7.64M
INSM icon
35
Insmed
INSM
$23.6B
$95.9M 0.99%
3,520,861
+135,216
+4% +$3.87M
RVMD icon
36
Revolution Medicines
RVMD
$39.1B
$87.3M 0.9%
3,470,162
+11,357
+0.3% +$320K
OPCH icon
37
Option Care Health
OPCH
$3.42B
$83.2M 0.86%
2,924,043
+328,229
+13% +$8.62M
KZR
38
DELISTED
Kezar Life Sciences
KZR
$82.2M 0.85%
491,815
+38,500
+8% +$4.35M
AMED
39
DELISTED
Amedisys
AMED
$79.3M 0.82%
490,012
+187,214
+62% +$30.1M
IDXX icon
40
Idexx Laboratories
IDXX
$44.4B
$77.7M 0.8%
117,979
-141
-0.1% -$88.5K
SWAV
41
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$76.1M 0.78%
426,610
-37,637
-8% -$7.42M
HCA icon
42
HCA Healthcare
HCA
$82.2B
$75.6M 0.78%
294,434
-47,039
-14% -$11.5M
VCRA
43
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$75.3M 0.78%
1,160,613
+6,572
+0.6% +$369K
SRPT icon
44
Sarepta Therapeutics
SRPT
$1.81B
$74.4M 0.77%
826,741
+257,573
+45% +$22M
CRSP icon
45
CRISPR Therapeutics
CRSP
$4.7B
$73.9M 0.76%
974,684
– –
EVH icon
46
Evolent Health
EVH
$661M
$72.2M 0.74%
2,609,293
-423,385
-14% -$12.1M
ACCD
47
DELISTED
Accolade Inc
ACCD
$71.7M 0.74%
2,721,375
+861,172
+46% +$28.2M
EPIX
48
DELISTED
ESSA Pharma
EPIX
$71.5M 0.74%
5,034,814
– –
MDT icon
49
Medtronic
MDT
$107B
$69M 0.71%
667,408
+328,283
+97% +$38M
CDNA icon
50
CareDx
CDNA
$1.99B
$66.7M 0.69%
1,466,552
+1,435,609
+4,640% +$74.9M
1
2
3 4 5

Similar funds

WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $4.22B AUM 21.28% 1-Year Est. Return
HIP
HUB Investment Partners Austin, Texas $4.18B AUM 24.76% 1-Year Est. Return
DT
DV Trading Chicago, Illinois $4.22B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.23B AUM 20.9% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.17B AUM 28.5% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $4.24B AUM 66.03% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

Bellevue Group's Q4 2021 Portfolio in Review

As of Q4 2021, Bellevue Group held 234 positions worth $9.7B, down 1.5% from $9.85B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Bellevue Group deployed $293M of net new capital in Q4 2021, opening 14 new positions and adding to 60 existing holdings. Its largest new stake was AstraZeneca: 29,500 shares worth $3.44M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 97% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Baxter International, an estimated $38.1M trimmed.

  • Bellevue Group's largest Q4 2021 buy was AstraZeneca: 29,500 shares worth $3.44M.
  • Bellevue Group added most to CareDx in Q4 2021, an estimated $74.9M increase.
  • Bellevue Group's biggest Q4 2021 reduction was Baxter International, cutting an estimated $38.1M.
  • Bellevue Group fully exited HILL-ROM HOLDINGS, INC. in Q4 2021, selling an estimated $63.1M.
  • Bellevue Group's ten largest holdings make up 30% of its $9.7B portfolio in Q4 2021.
  • Bellevue Group opened 14 new positions and closed 43 in Q4 2021.
  • Bellevue Group's portfolio value fell 1.5% quarter-over-quarter to $9.7B.

Based on Bellevue Group's 13F filing for Q4 2021, filed 10 Feb 2022.